Last €61.40 EUR
Change Today -0.013 / -0.02%
Volume 55.0
VX1 On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:04 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - vertex pharmaceuticals inc (VX1)

Name (Connections)Board RelationshipsTitleKey Developments
Bruce Sachs 65 RelationshipsCo- Lead Independent Director, Chairman of Management Development & Compensation Committee and Member of Audit & Finance Committee 
Elaine Ullian 83 RelationshipsCo-Lead Independent Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit & Finance Committee 
Terrence Kearney 16 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee 
Yuchun Lee 88 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Science & Technology Committee 

Compensation Committee* - vertex pharmaceuticals inc (VX1)

Name (Connections)Board RelationshipsTitle
Terrence Kearney 16 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee
Margaret McGlynn R.Ph 58 RelationshipsDirector and Member of Management Development & Compensation Committee
Bruce Sachs 65 RelationshipsCo- Lead Independent Director, Chairman of Management Development & Compensation Committee and Member of Audit & Finance Committee
VX1 Compensation vs. Industry
1.0M
387.9K
Chief Executive Officer
539.2K
276.9K
Chief Financial Officer
Share price activity for VERTEX PHARMACEUTICALS INC (VX1)
52 Week Price Performance
VX1
Industry Average

Nominating Committee* - vertex pharmaceuticals inc (VX1)

Name (Connections)Board RelationshipsTitleKey Developments
Elaine Ullian 83 RelationshipsCo-Lead Independent Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit & Finance CommitteeVertex Pharmaceuticals Incorporated Appoints Yuchun Lee as an Independent Director
09/18/12
Wayne Riley M.D., MPH, MBA, FACP 83 RelationshipsIndependent Director, Member of Corporate Governance & Nominating Committee and Member of Science & Technology CommitteeVertex Pharmaceuticals Incorporated Appoints Stuart A. Arbuckle as Executive Vice President and Chief Commercial Officer
09/4/12
David Altshuler M.D., Ph.D. 21 RelationshipsDirector, Member of Corporate Governance & Nominating Committee and Member of Science & Technology CommitteeVertex Pharmaceuticals Incorporated Announces Executive Changes
06/8/12

Corporate Governance Committee* - vertex pharmaceuticals inc (VX1)

Name (Connections)Board RelationshipsTitle
David Altshuler M.D., Ph.D. 21 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee
Wayne Riley M.D., MPH, MBA, FACP 83 RelationshipsDirector and Member of Management Development & Compensation Committee
Elaine Ullian 83 RelationshipsCo- Lead Independent Director, Chairman of Management Development & Compensation Committee and Member of Audit & Finance Committee
VX1 and Competitor
Insiders vs. External
Board
18%
82%
Vertex Pharmaceuticals Incorporated
22%
78%
Alkermes plc
6%
94%
BioMarin Pharmaceutical Inc.
13%
87%
Onyx Pharmaceuticals, Inc.
33%
67%
Regeneron Pharmaceuticals, Inc.
17%
83%
Jazz Pharmaceuticals Public Limited Company
Insiders
External Board Members

Advisory Committee* - vertex pharmaceuticals inc (VX1)

Name (Board Relationships)/Title Board Affiliations
Paul Anderson 95 Relationships
Member of Scientific Advisory Board
No other board affiliations
Steven Burakoff 60 Relationships
Member of Scientific Advisory Board
No other board affiliations
Lewis Cantley 67 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Harrison 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jeremy Knowles 65 Relationships
Member of Scientific Advisory Board
No other board affiliations
Peter Mueller 16 Relationships
Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of The Scientific Advisory Board
No other board affiliations
Robert Schooley 145 Relationships
Member of Scientific Advisory Board
No other board affiliations
Roger Tsien 31 Relationships
Member of Scientific Advisory Board
No other board affiliations

Finance Committee* - vertex pharmaceuticals inc (VX1)

Name(Connections)Board RelationshipsTitle
Terrence Kearney 16 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee
Yuchun Lee 88 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Science & Technology Committee
Bruce Sachs 65 RelationshipsCo- Lead Independent Director, Chairman of Management Development & Compensation Committee and Member of Audit & Finance Committee
Elaine Ullian 83 RelationshipsCo-Lead Independent Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit & Finance Committee
Debt To Total Capitalization43.1x
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VX1:GR €61.40 EUR -0.013

VX1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $31.98 USD +0.94
BioMarin Pharmaceutical Inc $65.00 USD +2.57
Jazz Pharmaceuticals Plc $60.00 USD +1.51
Onyx Pharmaceuticals Inc $92.91 USD -1.43
Regeneron Pharmaceuticals Inc $259.96 USD -3.68
View Industry Companies
 

Industry Analysis

VX1

Industry Average

Valuation VX1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.8x
Price/Book 22.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.5x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.